SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-20-019683
Filing Date
2020-04-29
Accepted
2020-04-29 16:00:19
Documents
5
Period of Report
2020-06-11
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A onct-def14a_20200611.htm DEF 14A 820852
2 GRAPHIC gybjxfbexmwe000003.jpg GRAPHIC 67485
3 GRAPHIC gybjxfbexmwe000004.jpg GRAPHIC 50796
4 GRAPHIC gybjxfbexmwe000001.jpg GRAPHIC 4172
5 GRAPHIC gybjxfbexmwe000002.jpg GRAPHIC 4172
  Complete submission text file 0001564590-20-019683.txt   996998
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50549 | Film No.: 20830085
SIC: 2834 Pharmaceutical Preparations